April 12, 2018 / 10:10 AM / 15 days ago

BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone In Stem-To-T-Cell Research Immuno Oncology Program

April 12 (Reuters) - ImmunoCellular Therapeutics Ltd :

* IMMUNOCELLULAR THERAPEUTICS ANNOUNCES ACHIEVEMENT OF NEXT KEY MILESTONE IN STEM-TO-T-CELL RESEARCH IMMUNO-ONCOLOGY PROGRAM

* BEEN ABLE TO VERIFY SUCCESSFUL TRANSFER OF SELECTED T CELL RECEPTOR GENETIC MATERIAL INTO HUMAN HEMATOPOIETIC STEM CELLS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below